Navigation Links
The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
Date:12/8/2011

JERUSALEM, December 8, 2011 /PRNewswire/ --

The Joint Management Authority of the European Neighbourhood and Partnership Instrument (ENPI CBC MED program) has informed Prof Nava Ben Zvi, President of Hadassah College in Israel that they will award a contract of up to 2 million Euro for the Bio-Xplore Project. This project, initiated and directed by Hadassah College, will be implemented in partnership with the Biodiversity and Environmental Research Center of the Palestinian Authority, Leitat Technological Center in Spain, and the Hellenic Regional Development Center in Greece. Two US-based Universities Rutgers University, New Jersey and the North Carolina State University, will also participate in the project.

Prof Bertold Fridlender, Director of Hadassah College's Biotechnology Department is the inspiration and driving force behind the BioXplore project. He explained: "the goal of the project is to identify endemic plants from the Mediterranean area, which contain compounds that may be valuable for industrial products such as pharmaceutical products, food additives, cosmetics and others. This collaborative research will promote social and financial developments in the Mediterranean Sea Basin Area."

As part of the Bio-Xplore project, a Mediterranean branch of the Global Institute for Bio-Exploration (GIBEX-MED) will be created. The GIBEX (http://www.gibex.org) centers are active today in Africa, America and Asia, and aim to initiate and support international joint research and development. These joint activities promote the development of biological products based on natural resources endemic to each of the partnering countries. The products are focused on achieving health and environmental targets in developing countries.  

Prof Nava Ben Zvi, President of Hadassah College, Jerusalem stated: "This program will enable collaboration on an academic level with industrial and business potential for each of the involved partners".

The project will be part of the curriculum of the Biotechnology Department in Hadassah College. The Department was founded to prepare students for joining the industrial workforce and continuing post graduate studies and research. According to Prof Fridlender: "The conditions, the knowledge and the minds in Israel today are an outstanding base for this project and we are confident in its success."  

Link to the program website:

http://www.enpicbcmed.eu/documenti/29_153_20111028122848.pdf

For more information: Yaniv Rosenberg, PR Hadassah College +972-50-4488962, yaniv@rcspr.co.il; Dan Shoshani, PR +972-523608508



'/>"/>
SOURCE Hadassah College
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Mergent, Inc. Announces Changes to the HealthShares(TM) European Drugs Index
2. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
3. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
4. ApoA-I Data Presented at European Society of Cardiology Congress
5. Trubion Pharmaceuticals Wins Patent Opposition - Genentech / Biogen Idec European Patent Revoked
6. Kuvan Receives Positive Opinion From CHMP for European Approval
7. Pharmaxis Research Programs Highlighted at European Respiratory Society Congress
8. Elseviers PharmaPendium(TM) Adds European Medicines Agency (EMEA) Documents
9. European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia
10. PRA International Addresses Sponsor-CRO Partnering Strategies at European Partnerships in Clinical Trials Congress
11. Oslo and Toulouse Cancer Clusters Join Forces to Drive European Cancer Research Forward
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... N.J. , Jan. 20, 2017 ... "Company"), a company that provides clinically useful molecular ... it has entered into a securities purchase agreement ... of 855,000 shares of common stock in a ... the Company has agreed to sell to the ...
(Date:1/20/2017)... -- Stock-Callers.com explores the Biotech industry to ... recent performances of select equities. In this morning,s lineup ... Abeona Therapeutics Inc. (NASDAQ: ABEO ), Theravance ... Therapeutics Inc. (NASDAQ: SAGE ). According to ... market size is expected to reach $604.40 billion by 2020 due to ...
(Date:1/19/2017)... 19, 2017  Market Research Future has a half cooked research ... Biopsy is growing rapidly and expected to reach USD 450 Million ... ... Biopsy Market has been assessed as a swiftly growing market and ... in the coming future. There has been a tremendous growth in ...
(Date:1/19/2017)... ... January 19, 2017 , ... November ... to leading biopharmaceutical and medical device manufacturers and regulators, is proud to announce ... Part 11-compliant email client designed to provide product vigilance departments with the flexibility ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, Inc. ... genomics technology company, announced today that on December 13, ... Department of The Nasdaq Stock Market LLC which acknowledged ... price of WaferGen,s common stock had been at $1.00 ... has regained compliance with Listing Rule 5550(a)(2) of the ...
(Date:12/15/2016)... , Dec. 15, 2016  There is much ... doors or starting the engine. Continental will demonstrate the ... Las Vegas . Through the combination of ... and Entry) and biometric elements, the international technology company ... vehicle personalization and authentication. "The integration of ...
(Date:12/8/2016)... Market Research Future published a half cooked research report on Mobile ... Service Market is expected to grow over the CAGR of ~35% ... ... Mobile Biometric Security and Service Market is increasing at ... and security from unwanted cyber threats. The increasing use of mobile ...
Breaking Biology News(10 mins):